Walgreens Boots Alliance Inc. (NASDAQ: WBA) reported a 25% drop in earnings for the first quarter of 2020 due to higher charges related to the acquisition of Rite Aid stores and the implementation of its transformational cost management program. The results missed analysts’ expectations.
Net earnings fell by 25% to $845 million or $0.95 per share. Adjusted earnings were $1.37 per share, down 6% on a reported basis and 5.7% on a constant currency basis from last year. Sales increased by 1.6% to $34.3 billion. On a constant currency basis, sales rose by 2.3%.
Looking ahead into fiscal 2020, the company still expects roughly flat growth in adjusted earnings per share at constant currency rates, with a range of plus or minus 3%.
Retail Pharmacy USA had sales growth of 1.6% as comparable-store sales increased by the same percentage. Pharmacy sales grew by 2.9% reflecting higher brand inflation and prescription volume, as well as strong growth in the central specialty. Comparable pharmacy sales increased by 2.5% and prescriptions filled in comparable stores increased by 2.8%.
Retail sales declined by 2.2%. Comparable retail sales were down 0.5% in the quarter, mostly due to continued de-emphasis of tobacco. Excluding tobacco and e-cigarettes, comparable retail sales increased around 0.8%, reflecting solid growth in the core health and wellness and beauty categories.
Retail Pharmacy International dropped by 5.4% reflecting an adverse currency impact of 2.7%. Sales decreased 2.7% on a constant currency basis, mainly due to lower retail sales in Boots UK and lower sales in Chile, reflecting social unrest.
Read: SmileDirectClub stock rebounds amid growth prospects concern
In Retail Pharmacy International, comparable pharmacy sales rose 0.6% on a constant currency basis, primarily due to the UK, driven by higher National Health Service (NHS) reimbursement and increased sales of services. Comparable retail sales declined by 3% on a constant currency basis, with Boots UK holding a share in a declining market.
Pharmaceutical Wholesale had first-quarter sales growth of 5.2% from the year-ago quarter, including an adverse currency impact of 3%. On a constant currency basis, comparable sales increased 8.3%, led by emerging markets and the UK, including a customer contract change in the UK.
The company remained on track to deliver in excess of $1.8 billion in annual cost savings by fiscal 2022 under the transformational cost management program. The company and McKesson agreed to create a German joint venture, combining their wholesale operations to drive long term value in a key European market. Walgreens and Kroger expanded their collaboration with a new joint venture aimed at delivering cost savings and other benefits across owned brand sourcing.
Most Popular
Microsoft (MSFT) reports higher revenue and profit for Q3 2024
Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,
GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results
Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was
MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales
Comments
Comments are closed.